|
|
S-008 / S-008-1ML updated item number format
Sufentanil Citrate
100 ug/mL (as free base) in Methanol | Certified Reference Material
|
Sufentanil is a short acting synthetic opioid analgesic most commonly used for pain relief during medical operations. This certified solution standard is applicable to use in clinical toxicology, pain prescription monitoring, or forensic analysis by LC-MS/MS or GC/MS. Sufentanil is sold under the trade name Sufenta.
|
|
|
|
Concentration:
|
100 ug/mL (as free base)
|
Solvent:
|
Methanol
|
Unit Size:
|
1 mL/ampoule
|
CAS Number:
|
60561-17-3
|
Chemical Formula:
|
C22H30N2O2S · C6H8O7
|
Molecular Weight:
|
578.67
|
Certificate of Analysis:
|
|
US List Price:
|
|
|
|
| A-071 / A-071-1ML |
|
Alfentanil HCl, 1.0 mg/mL (as free base)
|
|
$97.40
|
|
|
|
|
| B-066-0.5ML |
|
Butyryl fentanyl, 100 μg/mL
|
|
$114.00
|
|
|
|
|
| F-001 / F-001-1ML |
|
Fentanyl-D5, 100 μg/mL
|
|
$44.20
|
|
|
|
|
| F-002 / F-002-1ML |
|
Fentanyl, 100 μg/mL
|
|
$28.30
|
|
|
|
|
| F-013 / F-013-1ML |
|
Fentanyl, 1.0 mg/mL
|
|
$49.50
|
|
|
|
|
| N-030 / N-030-1ML |
|
Norfentanyl-D5 oxalate, 100 μg/mL (as free base)
|
|
$44.20
|
|
|
|
|
| N-031 / N-031-1ML |
|
Norfentanyl oxalate, 1.0 mg/mL (as free base)
|
|
$28.30
|
|
|
|
|
| N-055 / N-055-1ML |
|
Norfentanyl-D5 oxalate, 1.0 mg/mL (as free base)
|
|
$397.00
|
|
|
|
|
| P-071 / P-071-1ML |
|
Pain Management Multi-Component Opiate Mixture-13, 100 μg/mL of each component; 10 μg/mL of Fentanyl
|
|
$449.00
|
|
|
|
|
| R-024 / R-024-1ML |
|
Remifentanil HCl, 100 μg/mL (as free base)
|
|
$173.00
|
|
|
|
|
| R-026 / R-026-1ML |
|
Remifentanil acid, 100 μg/mL
|
|
$194.00
|
|
|
|
|
| S-018 / S-018-1ML |
|
Sufentanil-D5, 100 μg/mL
|
|
$248.00
|
|
|
|
|
Regulatory Control ▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required ▶ Canada Test Kit Registration # 61-1478 - no Health Canada import authorization required
read more about ordering regulated substances
UN Number, Class, PG UN2811, class 6.1, PG 2
Safety Data Sheet
HS Code
3822.90.0000
|
|
|
|